Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Fractional exhaled nitric oxide and blood eosinophils in relation to lung function, allergy and nasal polyps in asthma

Abohalaka, Reshed; Lehtimäki, Lauri; Ercan, Selin; Lisik, Daniil; Özuygur Ermis, Saliha Selin; Ilmarinen, Pinja; Pullerits, Teet; Backman, Helena; Rådinger, Madeleine; Nwaru, Bright I.; Kankaanranta, Hannu (2026-09)

 
Avaa tiedosto
Fractional_exhaled_nitric_oxide_and_blood_eosinophils_in_relation_to.pdf (11.35Mt)
Lataukset: 



Abohalaka, Reshed
Lehtimäki, Lauri
Ercan, Selin
Lisik, Daniil
Özuygur Ermis, Saliha Selin
Ilmarinen, Pinja
Pullerits, Teet
Backman, Helena
Rådinger, Madeleine
Nwaru, Bright I.
Kankaanranta, Hannu
09 / 2026

Journal of Allergy and Clinical Immunology: Global
100739
doi:10.1016/j.jacig.2026.100739
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202607158361

Kuvaus

Peer reviewed
Tiivistelmä
Background: Type 2 inflammation plays a central role in asthma, but blood eosinophil count (BEC) and fractional exhaled nitric oxide (FENO) levels may reflect different type 2 pathways. Their associations with different asthma characteristics in unselected populations remain unclear. Objectives: To examine how BEC and FENO, independently and synergistically, are related to lung function, allergy, and nasal polyps in a population-based asthma cohort. Methods: Data were analyzed from 1567 participants with physician-diagnosed asthma in the West Sweden Asthma Study. Lung function, bronchodilator responsiveness, and presence of allergy and nasal polyps were evaluated across categories of BEC and FENO labeled as low, medium, or high using various cutoffs. Associations were assessed using linear and logistic regression models in participants who were inhaled corticosteroid (ICS)-naive and ICS-treated separately. Results: Of participants, 49% (n = 767) were on ICS treatment at the time of examination. Among those who were ICS-treated, BEC, independently of FENO, was associated with reduced FEV1 and forced vital capacity percentages, higher nasal polyps and clinical allergy, and together with FENO contributed to bronchodilator responsiveness. Interaction effects between FENO and BEC were observed primarily for FEV1 and forced vital capacity percentages, at high range of cutoff values. In contrast, among participants who were ICS-naive, neither FENO nor BEC showed independent associations with outcomes; instead, their synergistic effect was associated with lower FEV1 and forced vital capacity percentages and a higher prevalence of clinical allergy, with consistent effects across a range of cutoff values. Conclusion: BEC and FENO reflect distinct yet complementary aspects of type 2 inflammation in asthma. These findings support the joint use of BEC and FENO for obstructive airway diseases phenotyping.
Kokoelmat
  • TUNICRIS-julkaisut [26189]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste